Related Experiment Video
Updated: Oct 17, 2025

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
Published on: August 12, 2016
Sugar intake from sweetened beverages and diabetes: A narrative review
Tung-Sung Tseng1, Wei-Ting Lin2, Gabrielle V Gonzalez3
1Behavioral and Community Health Sciences, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA 70112, United States. ttseng@lsuhsc.edu.
Reducing sugar-sweetened beverage (SSB) intake is crucial for managing type 2 diabetes mellitus (T2DM). Research confirms a link between SSBs, T2DM risk, and improved diabetes management strategies.
Area of Science:
- Nutrition Science
- Metabolic Disorders
- Public Health
Background:
- Type 2 diabetes mellitus (T2DM) is a global health crisis.
- Sugar-sweetened beverage (SSB) consumption is linked to adverse health outcomes in diabetic individuals.
- Lifestyle modifications like reduced SSB intake, weight control, and physical activity are key for diabetes prevention and management.
Purpose of the Study:
- To review the association between SSB consumption and T2DM risk.
- To explore the impact of obesity and inflammation on this relationship.
- To examine SSB consumption patterns in T2DM patients.
Main Methods:
- Literature review methodology.
- Synthesis of existing research on SSB intake and T2DM.
- Analysis of studies on obesity, inflammation, and T2DM risk factors.
Main Results:
- Evidence confirms a significant association between SSB consumption and increased T2DM risk.
- Specific types of SSBs and their differential impact on T2DM were examined.
- Obesity and inflammation mediate the link between SSBs and T2DM development.
Conclusions:
- Current research strongly supports the connection between SSBs, T2DM risk, and diabetes management.
- Further investigation is needed to develop effective SSB-related interventions for diabetes prevention and control.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:

